Lipid Metabolism — MCQs

A newborn infant presents with severe respiratory problems, muscle problems, minimal development, and neurological deficits. A liver biopsy shows very low acetyl CoA carboxylase activity, with normal activity of enzymes involved in glycolysis, gluconeogenesis, the citric acid cycle, and the pentose phosphate pathway. What is the most likely cause of the infant's respiratory problems?

Q226Easy

Which of the following occurs in mitochondria?

Q227Easy

What is the richest source of triglycerides in the blood?

Q228Easy

What is the main fatty acid in cholesterol?

Q229Easy

HMG-CoA can be directly converted to all except?

Q230Easy

Beta-oxidation of fatty acids with an odd number of carbon atoms yields which of the following?

Lipid Metabolism Indian Medical PG Practice Questions and MCQs

Question 221: All of the following are true statements regarding the regulation of cholesterol synthesis, EXCEPT?

A. Binding of SREBP to SRE enhances the transcription of HMG-CoA reductase
B. HMG-CoA reductase is active in phosphorylated form (Correct Answer)
C. Insig1 is involved in the degradation of HMG-CoA reductase
D. Mevalonate inhibits the HMG-CoA reductase

Explanation: **Explanation:** The rate-limiting step of cholesterol synthesis is the conversion of HMG-CoA to mevalonate, catalyzed by the enzyme **HMG-CoA Reductase**. **1. Why Option B is the Correct Answer (The Exception):** HMG-CoA reductase is regulated by covalent modification. It is **active in the dephosphorylated state** and **inactive in the phosphorylated state**. This phosphorylation is carried out by the AMP-activated protein kinase (AMPK). In states of low energy (high AMP), the enzyme is phosphorylated and turned off to conserve energy. Conversely, insulin promotes dephosphorylation, activating the enzyme. **2. Analysis of Other Options:** * **Option A:** When cholesterol levels are low, **SREBP** (Sterol Regulatory Element Binding Protein) moves to the nucleus and binds to **SRE** (Sterol Regulatory Element) on the DNA, increasing the transcription of the HMG-CoA reductase gene. * **Option C:** **Insig-1** (Insulin-induced gene) acts as a sensor. When sterol levels are high, Insig binds to HMG-CoA reductase, leading to its ubiquitination and subsequent **proteasomal degradation**. * **Option D:** **Mevalonate** is the immediate product of the reaction. High levels of mevalonate exert **feedback inhibition** on HMG-CoA reductase to prevent overproduction of cholesterol. **Clinical Pearls for NEET-PG:** * **Statins:** These are competitive inhibitors of HMG-CoA reductase (structural analogs of HMG-CoA). * **Diurnal Variation:** Cholesterol synthesis is maximal at night; hence, statins with short half-lives (like Simvastatin) are taken at bedtime. * **Hormonal Control:** Insulin and Thyroxine **upregulate** the enzyme, while Glucagon and Glucocorticoids **downregulate** it.

Question 222: Which is the most important Essential Fatty Acid?

A. Linoleic Acid (Correct Answer)
B. Linolenic Acid
C. Arachidonic Acid
D. Eicosapentanoic Acid

Explanation: **Explanation:** **Linoleic Acid (Omega-6)** is considered the most important essential fatty acid (EFA) because it is the **primary precursor** for the synthesis of other critical fatty acids, most notably Arachidonic acid. Humans lack the enzymes ($\Delta^{12}$ and $\Delta^{15}$ desaturases) required to introduce double bonds beyond the $\Delta^9$ position, making dietary intake of Linoleic acid mandatory. It is the "true" essential fatty acid because if Linoleic acid is provided in sufficient quantities, the body can synthesize Arachidonic acid. **Analysis of Options:** * **Linoleic Acid (Option A):** Correct. It is the most abundant EFA in the diet and serves as the starting point for the Omega-6 pathway. Deficiency leads to scaly skin (phrynoderma) and poor wound healing. * **Linolenic Acid (Option B):** Also an EFA (Omega-3), but Linoleic acid is prioritized in medical literature as "most important" because it is the most prevalent in the diet and serves as a precursor for a wider range of prostanoids. * **Arachidonic Acid (Option C):** It is considered **semi-essential**. It only becomes essential if its precursor, Linoleic acid, is deficient in the diet. * **Eicosapentaenoic Acid (Option D):** An Omega-3 fatty acid derived from $\alpha$-Linolenic acid; it is not a primary essential fatty acid. **High-Yield Clinical Pearls for NEET-PG:** * **Phrynoderma (Toad Skin):** Characterized by follicular hyperkeratosis; it is a classic sign of EFA deficiency. * **Eicosanoid Precursor:** Arachidonic acid is the direct precursor for Prostaglandins, Thromboxanes, and Leukotrienes. * **Essentiality Hierarchy:** Linoleic Acid > Linolenic Acid > Arachidonic Acid. * **Ratio:** The ideal dietary ratio of Omega-6 to Omega-3 is roughly 4:1 to 10:1.

Question 223: Which fatty acid is synthesized first in humans?

A. Linoleic acid (Correct Answer)
B. Stearic acid
C. Palmitic acid
D. Oleic acid

Explanation: The correct answer is **Palmitic acid (Option C)**. *Note: There appears to be a discrepancy in the provided key. In human biochemistry, Palmitic acid is the primary product of the Fatty Acid Synthase (FAS) complex.* ### **Explanation** **1. Why Palmitic Acid is the correct answer:** The de novo synthesis of fatty acids (Lipogenesis) occurs primarily in the cytosol of the liver and lactating mammary glands. The multi-enzyme complex, **Fatty Acid Synthase (FAS)**, catalyzes the synthesis of fatty acids starting from Acetyl-CoA and Malonyl-CoA. This process terminates specifically at the 16-carbon saturated fatty acid, **Palmitic acid (16:0)**. All other long-chain fatty acids in the body are derived from palmitic acid through subsequent elongation and desaturation. **2. Why the other options are incorrect:** * **Stearic acid (18:0):** This is synthesized by the **elongation** of palmitic acid in the mitochondria or endoplasmic reticulum. It is not the "first" product. * **Oleic acid (18:1; ω-9):** This is a monounsaturated fatty acid formed by the **desaturation** of stearic acid via the enzyme Δ9-desaturase. * **Linoleic acid (18:2; ω-6):** This is an **essential fatty acid**. Humans lack the enzymes (Δ12 and Δ15 desaturases) to introduce double bonds beyond carbon 9. Therefore, linoleic acid cannot be synthesized by humans at all and must be obtained from the diet. ### **High-Yield Clinical Pearls for NEET-PG** * **Rate-limiting enzyme:** Acetyl-CoA Carboxylase (requires **Biotin**). * **Reductant:** **NADPH** is the essential electron donor for fatty acid synthesis (primarily sourced from the HMP Shunt). * **Citrate Shuttle:** Acetyl-CoA enters the cytosol from the mitochondria in the form of Citrate. * **Essential Fatty Acids:** Linoleic acid (ω-6) and α-Linolenic acid (ω-3). Deficiency leads to **Phrynoderma** (toad skin).

Question 224: Which of the following is NOT involved in imparting rancidity to fats?

A. Oxidation
B. Hydrolysis
C. Reduction (Correct Answer)
D. Cyclization of hydrocarbons

Explanation: **Explanation:** Rancidity refers to the chemical decomposition of fats and oils, resulting in an unpleasant odor and taste. It occurs primarily through the degradation of fatty acid chains. **Why Reduction is the Correct Answer:** Reduction is the process of adding hydrogen atoms to unsaturated bonds (hydrogenation). In the food industry, partial reduction is actually used to **prevent** rancidity by converting unstable unsaturated fatty acids into more stable saturated ones (e.g., making margarine). Therefore, reduction inhibits rather than imparts rancidity. **Analysis of Other Options:** * **Oxidation (Oxidative Rancidity):** This is the most common cause. Free radicals attack the double bonds of unsaturated fatty acids, forming peroxides and aldehydes (like malondialdehyde), which produce the characteristic foul smell. * **Hydrolysis (Hydrolytic Rancidity):** This occurs when lipase enzymes (from bacteria) or moisture break the ester bonds of triglycerides, releasing free fatty acids. Short-chain fatty acids like butyric acid are particularly pungent. * **Cyclization of Hydrocarbons:** During high-heat processing (like deep frying), fatty acid chains can undergo cyclization and polymerization. These cyclic compounds contribute to the chemical spoilage and potential toxicity of the fat. **High-Yield NEET-PG Pearls:** * **Antioxidants:** Vitamin E (Tocopherol), Vitamin C, BHA, and BHT are added to fats to prevent oxidative rancidity by scavenging free radicals. * **Marker of Lipid Peroxidation:** Malondialdehyde (MDA) is a key biochemical marker used to measure the degree of lipid peroxidation/oxidative stress. * **Vegetable Oils:** These are more prone to oxidative rancidity than animal fats because they contain higher levels of polyunsaturated fatty acids (PUFAs).

Question 225: A newborn infant presents with severe respiratory problems, muscle problems, minimal development, and neurological deficits. A liver biopsy shows very low acetyl CoA carboxylase activity, with normal activity of enzymes involved in glycolysis, gluconeogenesis, the citric acid cycle, and the pentose phosphate pathway. What is the most likely cause of the infant's respiratory problems?

A. Low levels of phosphatidylcholine (Correct Answer)
B. Biotin deficiency
C. Ketoacidosis
D. High levels of citrate

Explanation: **Explanation:** The core of this question lies in understanding the role of **Acetyl CoA Carboxylase (ACC)** in fatty acid synthesis and its downstream effects on lung physiology. **1. Why Option A is Correct:** Acetyl CoA Carboxylase is the **rate-limiting enzyme** for the synthesis of long-chain fatty acids (converting Acetyl CoA to Malonyl CoA). Fatty acids are essential building blocks for **Dipalmitoylphosphatidylcholine (DPPC)**, also known as **Lecithin**. DPPC is the primary phospholipid component of **pulmonary surfactant**. A deficiency in ACC leads to decreased fatty acid production, resulting in surfactant deficiency. This causes high alveolar surface tension, leading to atelectasis and severe respiratory distress syndrome (RDS). **2. Why Incorrect Options are Wrong:** * **B. Biotin deficiency:** While ACC is a biotin-dependent enzyme, a primary biotin deficiency would also affect other carboxylases (like Pyruvate Carboxylase), disrupting gluconeogenesis. The question states gluconeogenesis is normal. * **C. Ketoacidosis:** Low ACC activity actually *decreases* Malonyl CoA levels. Since Malonyl CoA normally inhibits CPT-1, its absence would accelerate fatty acid oxidation and potentially increase ketone bodies, but this does not explain the primary respiratory pathology. * **D. High levels of citrate:** Citrate is an allosteric activator of ACC. If ACC activity is low due to a primary enzyme defect, citrate levels might rise as it isn't being utilized, but this is a metabolic consequence, not the *cause* of respiratory failure. **High-Yield Clinical Pearls for NEET-PG:** * **Surfactant Composition:** 90% lipids (mainly DPPC/Lecithin) and 10% proteins (SP-A, B, C, D). * **L/S Ratio:** A Lecithin/Sphingomyelin ratio > 2.0 in amniotic fluid indicates fetal lung maturity. * **ACC Regulation:** Stimulated by Citrate and Insulin; inhibited by Palmitoyl-CoA and Glucagon (via phosphorylation).

Question 226: Which of the following occurs in mitochondria?

A. Glycolysis
B. HMP shunt
C. TCA cycle (Correct Answer)
D. Glycogenesis

Explanation: **Explanation:** The correct answer is **C. TCA cycle**. In cellular metabolism, biochemical pathways are compartmentalized to ensure metabolic efficiency and regulation. The **TCA cycle (Krebs cycle)**, along with the Electron Transport Chain (ETC), Beta-oxidation of fatty acids, and Ketogenesis, occurs exclusively within the **mitochondrial matrix**. This is because the necessary enzymes (such as Citrate Synthase and Isocitrate Dehydrogenase) and the high concentration of $NAD^+$ required for these oxidative processes are localized there. **Analysis of Incorrect Options:** * **A. Glycolysis:** This is the primary pathway for glucose breakdown and occurs entirely in the **cytosol**. * **B. HMP Shunt (Pentose Phosphate Pathway):** This pathway, which generates NADPH and ribose-5-phosphate, takes place in the **cytosol**. * **D. Glycogenesis:** The synthesis of glycogen from glucose occurs in the **cytosol** of liver and muscle cells. **High-Yield NEET-PG Pearls:** 1. **Purely Mitochondrial:** TCA cycle, Beta-oxidation, Ketogenesis, Pyruvate Dehydrogenase (PDH) complex. 2. **Purely Cytosolic:** Glycolysis, HMP Shunt, Fatty acid synthesis, Cholesterol synthesis, Glycogenesis, and Glycogenolysis. 3. **Both (Dual Compartmentalization):** "HUG" mnemonic — **H**eme synthesis, **U**rea cycle, and **G**luconeogenesis. 4. **Exception:** All enzymes of the TCA cycle are in the mitochondrial matrix except **Succinate Dehydrogenase**, which is located on the inner mitochondrial membrane (acting as Complex II of the ETC).

Question 227: What is the richest source of triglycerides in the blood?

A. HDL (High-Density Lipoprotein)
B. LDL (Low-Density Lipoprotein)
C. VLDL (Very-Low-Density Lipoprotein) (Correct Answer)
D. Chylomicrons

Explanation: ### Explanation The correct answer is **VLDL (Very-Low-Density Lipoprotein)**. **Why VLDL is the correct answer:** Triglycerides (TGs) are transported in the blood primarily by two lipoproteins: **Chylomicrons** and **VLDL**. * **Chylomicrons** carry exogenous (dietary) TGs from the intestines to peripheral tissues. They are the largest lipoproteins and have the highest *percentage* of TGs (approx. 90%). However, they are only present in the blood post-prandially (after a meal). * **VLDL** carries endogenous TGs synthesized in the liver. In a **fasting state**, VLDL is the primary carrier and the richest source of triglycerides in the plasma. Since standard lipid profiles are measured after fasting, VLDL is clinically considered the major source of circulating TGs. **Why the other options are incorrect:** * **Chylomicrons:** While they have a higher TG-to-protein ratio than VLDL, they are transient and absent in normal fasting blood. (Note: If the question specifies "post-prandial," Chylomicrons would be the answer). * **LDL:** Known as "bad cholesterol," its primary cargo is **cholesterol esters**, not triglycerides. * **HDL:** Known as "good cholesterol," it has the highest **protein content** and is involved in reverse cholesterol transport. **High-Yield Clinical Pearls for NEET-PG:** * **Apo-B100** is the characteristic marker for VLDL, IDL, and LDL. * **Apo-B48** is unique to Chylomicrons. * **Lipoprotein Lipase (LPL)** is the enzyme responsible for clearing TGs from both Chylomicrons and VLDL. * **Type IV Hyperlipoproteinemia** is characterized by isolated elevation of VLDL.

Question 228: What is the main fatty acid in cholesterol?

A. Linoleic
B. Oleic
C. None of the above (Correct Answer)
D. Arachidonic

Explanation: **Explanation:** The correct answer is **None of the above** because **cholesterol is not a fatty acid.** **1. Why the correct answer is right:** Cholesterol is a **sterol** (a steroid alcohol) consisting of four fused hydrocarbon rings (the steroid nucleus) and an 8-carbon hydrocarbon tail. It does not contain any fatty acid chains in its structure. While cholesterol can be esterified with a fatty acid to form a **cholesteryl ester** (the storage and transport form), "cholesterol" itself is a distinct lipid molecule. **2. Why the incorrect options are wrong:** * **Linoleic Acid (A):** This is an essential polyunsaturated fatty acid (PUFA). While it is the most common fatty acid found in **cholesteryl esters** circulating in human plasma (LDL), it is not a part of the cholesterol molecule itself. * **Oleic Acid (B):** This is a monounsaturated fatty acid. It is the primary fatty acid found in cholesteryl esters stored within **cells** (via the enzyme ACAT), but again, it is not a component of the cholesterol molecule. * **Arachidonic Acid (D):** This is a 20-carbon PUFA used for eicosanoid synthesis. It is found in membrane phospholipids but is not a structural component of cholesterol. **3. High-Yield NEET-PG Pearls:** * **Precursor:** All 27 carbon atoms of cholesterol are derived from **Acetyl-CoA**. * **Rate-limiting enzyme:** HMG-CoA Reductase (inhibited by Statins). * **Cholesteryl Ester Formation:** * **In Plasma:** Catalyzed by **LCAT** (Lecithin-Cholesterol Acyltransferase); prefers Linoleic acid. * **In Cells:** Catalyzed by **ACAT** (Acyl-CoA:Cholesterol Acyltransferase); prefers Oleic acid. * **Detection:** The **Libermann-Burchard reaction** is the classic chemical test for cholesterol (turns emerald green).

Question 229: HMG-CoA can be directly converted to all except?

A. Acetoacetate
B. Acetyl-CoA
C. Mevalonate
D. Acetoacetyl CoA (Correct Answer)

Explanation: ### Explanation The question tests your knowledge of the metabolic fates of **3-hydroxy-3-methylglutaryl-CoA (HMG-CoA)**, a central intermediate in both ketogenesis and cholesterol synthesis. #### Why Acetoacetyl CoA is the Correct Answer HMG-CoA is **synthesized from** Acetoacetyl CoA and Acetyl-CoA by the enzyme *HMG-CoA synthase*. The reaction is: **Acetoacetyl CoA + Acetyl-CoA → HMG-CoA** Metabolic pathways do not "directly" convert HMG-CoA back into Acetoacetyl CoA in a single step; rather, it is broken down into Acetoacetate and Acetyl-CoA. Therefore, Acetoacetyl CoA is a precursor, not a direct product. #### Analysis of Incorrect Options * **A & B (Acetoacetate and Acetyl-CoA):** In the mitochondria (Ketogenesis), the enzyme **HMG-CoA Lyase** cleaves HMG-CoA directly into Acetoacetate (a ketone body) and Acetyl-CoA. * **C (Mevalonate):** In the cytosol (Cholesterol synthesis), the rate-limiting enzyme **HMG-CoA Reductase** reduces HMG-CoA directly into Mevalonate using NADPH. #### NEET-PG High-Yield Pearls * **Compartmentalization:** HMG-CoA for **ketogenesis** occurs in the **mitochondria** (Liver), while HMG-CoA for **cholesterol synthesis** occurs in the **cytosol/ER**. * **Rate-Limiting Step:** HMG-CoA Reductase is the target of **Statins**, which are competitive inhibitors used to treat hypercholesterolemia. * **Ketogenic Enzyme:** HMG-CoA Lyase deficiency is a rare organic aciduria that presents with non-ketotic hypoglycemia. * **Mnemonic:** "Lyase for Lipids (Ketones), Reductase for Ring (Cholesterol)."

Question 230: Beta-oxidation of fatty acids with an odd number of carbon atoms yields which of the following?

A. Acetyl CoA
B. Propionyl CoA
C. Both Acetyl CoA and Propionyl CoA (Correct Answer)
D. None of the above

Explanation: **Explanation:** **Understanding the Concept:** Beta-oxidation is the primary pathway for the catabolism of fatty acids, occurring in the mitochondrial matrix. For even-chain fatty acids, the process repeatedly cleaves two-carbon units to produce only **Acetyl CoA**. However, for **odd-chain fatty acids**, the process proceeds identically until the final cycle. In the last step, a five-carbon fragment remains. The cleavage of this fragment results in one molecule of **Acetyl CoA** (2 carbons) and one molecule of **Propionyl CoA** (3 carbons). Therefore, the complete oxidation of an odd-chain fatty acid yields multiple molecules of Acetyl CoA and exactly one molecule of Propionyl CoA. **Analysis of Options:** * **Option A (Acetyl CoA):** While Acetyl CoA is produced in every spiral of beta-oxidation, selecting this alone is incomplete for odd-chain fatty acids. * **Option B (Propionyl CoA):** This is the unique end-product of odd-chain oxidation, but it is produced alongside Acetyl CoA, not in isolation. * **Option C (Correct):** This accurately reflects that both 2-carbon and 3-carbon units are generated during the final cleavage. **NEET-PG High-Yield Pearls:** 1. **Gluconeogenesis:** Unlike even-chain fatty acids, odd-chain fatty acids are **glucogenic**. Propionyl CoA is converted to Succinyl CoA (a TCA cycle intermediate), which can enter the gluconeogenic pathway. 2. **Metabolic Pathway:** Propionyl CoA → D-Methylmalonyl CoA → L-Methylmalonyl CoA → **Succinyl CoA**. 3. **Cofactors:** This conversion requires **Biotin (B7)** for the carboxylase step and **Vitamin B12 (Cobalamin)** for the mutase step. 4. **Clinical Correlation:** Vitamin B12 deficiency leads to the accumulation of Methylmalonic acid (Methylmalonic Aciduria) and secondary neurological damage due to the incorporation of abnormal fatty acids into myelin.

Practice by Chapter

Lipid Classification and Chemistry

Practice Questions

Fatty Acid Oxidation

Practice Questions

Ketone Body Metabolism

Practice Questions

Fatty Acid Synthesis

Practice Questions

Metabolism of Triacylglycerols

Practice Questions

Phospholipid Metabolism

Practice Questions

Cholesterol Metabolism and Biosynthesis

Practice Questions

Bile Acids and Bile Salts

Practice Questions

Lipoprotein Metabolism and Transport

Practice Questions

Dyslipidemias and Atherosclerosis

Practice Questions

Prostaglandins and Eicosanoids

Practice Questions

Fatty Liver and Lipotropic Factors

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free